191 related articles for article (PubMed ID: 15632159)
1. Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations.
Fioriti L; Dossena S; Stewart LR; Stewart RS; Harris DA; Forloni G; Chiesa R
J Biol Chem; 2005 Mar; 280(12):11320-8. PubMed ID: 15632159
[TBL] [Abstract][Full Text] [Related]
2. Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons.
Roucou X; Guo Q; Zhang Y; Goodyer CG; LeBlanc AC
J Biol Chem; 2003 Oct; 278(42):40877-81. PubMed ID: 12917444
[TBL] [Abstract][Full Text] [Related]
3. Expression of mutant or cytosolic PrP in transgenic mice and cells is not associated with endoplasmic reticulum stress or proteasome dysfunction.
Quaglio E; Restelli E; Garofoli A; Dossena S; De Luigi A; Tagliavacca L; Imperiale D; Migheli A; Salmona M; Sitia R; Forloni G; Chiesa R
PLoS One; 2011 Apr; 6(4):e19339. PubMed ID: 21559407
[TBL] [Abstract][Full Text] [Related]
4. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation.
Drisaldi B; Stewart RS; Adles C; Stewart LR; Quaglio E; Biasini E; Fioriti L; Chiesa R; Harris DA
J Biol Chem; 2003 Jun; 278(24):21732-43. PubMed ID: 12663673
[TBL] [Abstract][Full Text] [Related]
5. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol.
Ma J; Wollmann R; Lindquist S
Science; 2002 Nov; 298(5599):1781-5. PubMed ID: 12386337
[TBL] [Abstract][Full Text] [Related]
6. Calpain and other cytosolic proteases can contribute to the degradation of retro-translocated prion protein in the cytosol.
Wang X; Wang F; Sy MS; Ma J
J Biol Chem; 2005 Jan; 280(1):317-25. PubMed ID: 15525638
[TBL] [Abstract][Full Text] [Related]
7. The retention of prion protein in the endoplasmic reticulum prevents N2A cells from proteasome inhibition-induced cytotoxicity.
Fang S; Wang R; Liu H; Zhuang W; Wang Z; Zhang J; Pei L; Liu Y; Su Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):500-507. PubMed ID: 28669732
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation.
Chiesa R; Drisaldi B; Quaglio E; Migheli A; Piccardo P; Ghetti B; Harris DA
Proc Natl Acad Sci U S A; 2000 May; 97(10):5574-9. PubMed ID: 10805813
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitors promote the sequestration of PrPSc into aggresomes within the cytosol of prion-infected CAD neuronal cells.
Dron M; Dandoy-Dron F; Farooq Salamat MK; Laude H
J Gen Virol; 2009 Aug; 90(Pt 8):2050-2060. PubMed ID: 19339478
[TBL] [Abstract][Full Text] [Related]
10. Selective processing and metabolism of disease-causing mutant prion proteins.
Ashok A; Hegde RS
PLoS Pathog; 2009 Jun; 5(6):e1000479. PubMed ID: 19543376
[TBL] [Abstract][Full Text] [Related]
11. Mutant prion protein expression is associated with an alteration of the Rab GDP dissociation inhibitor alpha (GDI)/Rab11 pathway.
Massignan T; Biasini E; Lauranzano E; Veglianese P; Pignataro M; Fioriti L; Harris DA; Salmona M; Chiesa R; Bonetto V
Mol Cell Proteomics; 2010 Apr; 9(4):611-22. PubMed ID: 19996123
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein 70 selectively mediates the degradation of cytosolic PrPs and restores the cytosolic PrP-induced cytotoxicity via a molecular interaction.
Zhang J; Wang K; Guo Y; Shi Q; Tian C; Chen C; Gao C; Zhang BY; Dong XP
Virol J; 2012 Dec; 9():303. PubMed ID: 23216755
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
14. Cytosolic prion protein toxicity is independent of cellular prion protein expression and prion propagation.
Norstrom EM; Ciaccio MF; Rassbach B; Wollmann R; Mastrianni JA
J Virol; 2007 Mar; 81(6):2831-7. PubMed ID: 17182694
[TBL] [Abstract][Full Text] [Related]
15. The neurotoxicity of prion protein (PrP) peptide 106-126 is independent of the expression level of PrP and is not mediated by abnormal PrP species.
Fioriti L; Quaglio E; Massignan T; Colombo L; Stewart RS; Salmona M; Harris DA; Forloni G; Chiesa R
Mol Cell Neurosci; 2005 Jan; 28(1):165-76. PubMed ID: 15607951
[TBL] [Abstract][Full Text] [Related]
16. Proteasomal Inhibition Redirects the PrP-Like Shadoo Protein to the Nucleus.
Kang SG; Mays CE; Daude N; Yang J; Kar S; Westaway D
Mol Neurobiol; 2019 Nov; 56(11):7888-7904. PubMed ID: 31129810
[TBL] [Abstract][Full Text] [Related]
17. Conditions of endoplasmic reticulum stress favor the accumulation of cytosolic prion protein.
Orsi A; Fioriti L; Chiesa R; Sitia R
J Biol Chem; 2006 Oct; 281(41):30431-8. PubMed ID: 16908519
[TBL] [Abstract][Full Text] [Related]
18. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol.
Ma J; Lindquist S
Science; 2002 Nov; 298(5599):1785-8. PubMed ID: 12386336
[TBL] [Abstract][Full Text] [Related]
19. A transmembrane form of the prion protein is localized in the Golgi apparatus of neurons.
Stewart RS; Harris DA
J Biol Chem; 2005 Apr; 280(16):15855-64. PubMed ID: 15671025
[TBL] [Abstract][Full Text] [Related]
20. An overlapping reading frame in the PRNP gene encodes a novel polypeptide distinct from the prion protein.
Vanderperre B; Staskevicius AB; Tremblay G; McCoy M; O'Neill MA; Cashman NR; Roucou X
FASEB J; 2011 Jul; 25(7):2373-86. PubMed ID: 21478263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
